Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.
Veniti, formed in 2009, specializes in devices for the venous anatomy, an arena often covered in a larger medical device company’s vascular devices business.
"In order to truly understand and appreciate venous disease you really need to focus in on what venous disease really is," Morris told MassDevice. "You need to put a stake in the ground and really focus on venous disease, and that’s got to be aligning sales and marketing and R&D – everybody from the CFO to the rep on the street and everybody in between needs to understand and appreciate venous disease for the company to win."
And Morris is certainly looking to win. Veniti’s logo, emblazoned on every page of the website, features the Latin phrase "Veni, vidi, vici," purportedly spoken by Julius Caesar and meaning "I came, I saw, I conquered."
"Given we are the first company with multiple products in the venous disease space, we certainly have arrived," Morris said. "We are looking into venous disease, so we’re seeing it on a daily basis. And of course we intend to conquer the new, emerging, growing space by virtue of the talent that we’ve assembled and the technology that we’re working on."
The company is preparing to penetrate the market with a 3-pronged approach that includes its Veni RF Plus radiofrequency ablation system for treatment of varicose veins, the Veniti vena cava filter and the industry’s 1st vein-specific stent.
In an exclusive interview with MassDevice, Morris told us how Veniti was born, why generic vascular devices aren’t the best approach to treating venous disease and what we can expect from the company in the months ahead.